Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy
Cideciyan, A. V. ORCID: 0000-0002-2018-0905, Roman, A. J. ORCID: 0000-0001-7368-3007, Warner, R. L. , Sumaroka, A., Wu, V., Jiang, Y. Y., Swider, M., Garafalo, A. V., Viarbitskaya, I., Russell, R. C., Kohl, S. ORCID: 0000-0002-6438-6331, Wissinger, B. ORCID: 0000-0001-8964-5953, Ripamonti, C., Barbur, J. L. ORCID: 0000-0002-2187-5004, Bach, M. ORCID: 0000-0003-2028-535X, Carroll, J. ORCID: 0000-0002-8640-1029, Morgan, J. I. W. ORCID: 0000-0002-9878-7336 & Aleman, T. S. (2024). Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy. International Journal of Molecular Sciences, 25(19), article number 10639. doi: 10.3390/ijms251910639
Abstract
L-cone opsin expression by gene therapy is a promising treatment for blue cone monochromacy (BCM) caused by congenital lack of long- and middle-wavelength-sensitive (L/M) cone function. Eight patients with BCM and confirmed pathogenic variants at the OPN1LW/OPN1MW gene cluster participated. Optical coherence tomography (OCT), chromatic perimetry, chromatic microperimetry, chromatic visual acuity (VA), and chromaticity thresholds were performed with unmodified commercial equipment and/or methods available in the public domain. Adaptive optics scanning laser ophthalmoscope (AOSLO) imaging was performed in a subset of patients. Outer retinal changes were detectable by OCT with an age-related effect on the foveal disease stage. Rod and short-wavelength-sensitive (S) cone functions were relatively retained by perimetry, although likely impacted by age-related increases in the pre-retinal absorption of short-wavelength lights. The central macula showed a large loss of red sensitivity on dark-adapted microperimetry. Chromatic VAs with high-contrast red gratings on a blue background were not detectable. Color vision was severely deficient. AOSLO imaging showed reduced total cone density with majority of the population being non-waveguiding. This study developed and evaluated specialized outcomes that will be needed for the determination of efficacy and safety in human clinical trials. Dark-adapted microperimetry with a red stimulus sampling the central macula would be a key endpoint to evaluate the light sensitivity improvements. VA changes specific to L-opsin can be measured with red gratings on a bright blue background and should also be considered as outcome measures in future interventional trials.
Publication Type: | Article |
---|---|
Additional Information: | © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
Publisher Keywords: | color vision; microperimetry; outcome measures; perimetry |
Subjects: | Q Science > QH Natural history > QH426 Genetics R Medicine > RC Internal medicine R Medicine > RE Ophthalmology |
Departments: | School of Health & Psychological Sciences School of Health & Psychological Sciences > Optometry & Visual Sciences |
SWORD Depositor: |
Available under License Creative Commons: Attribution International Public License 4.0.
Download (7MB) | Preview
Export
Downloads
Downloads per month over past year